HTG: HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
HTG Molecular Diagnostics, Inc., a platform-based life science tools and drug discovery company, reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlights.
Read full article »
HTG is an Arizona-based RNA platform that automates sample processing for molecular profiling applications.
Read more